Personalising magnetic brain stimulation for treatment-resistant depression
People with treatment-resistant depression can remain unwell after medication and psychotherapy. Conventional magnetic brain stimulation uses standard targeting methods, while patients differ in the brain networks involved in their symptoms and may need many visits over several weeks.
Connectoma Neurotech helps specialist clinics offer personalised brain-stimulation treatment to people whose depression has not improved with conventional care. Individual treatment targeting and an intensive outpatient schedule aim to make treatment more precise and easier to complete.
What stands out about Connectoma Neurotech
Connectoma opened its first Madrid treatment centre with Veram, offering personalised magnetic stimulation for resistant depression.
Connectoma announced €1.25M in initial financing in April 2026, with investors including psychiatrist Marian Rojas Estapé.
Imaging group HT Médica integrated functional MRI into Connectoma’s Seville treatment-planning workflow for personalised stimulation.
Co-founder Jaime Adán Manes led psychiatry at Ruber Internacional’s Habana centre from 2017 to 2025 and practised as an NHS psychiatrist.
Co-founder Daniel Díez previously founded Bit2Me, Blockchain Toolkit and blockchain consultancy Furai.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.